Title : Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma.

Pub. Date : 2022 Jun

PMID : 35461090






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The treatment of PCNSL is ineffective partly due to the blood-brain barrier (BBB) restriction of delivery of many drugs including anti-CD20 (Rituximab; RTX) which is a standard treatment for systemic B-cell lymphomas. resiniferatoxin keratin 20 Homo sapiens